Glucomannan
What the study found
A meta-analysis of six randomized controlled trials reported reductions in fasting glucose, postprandial glucose and several lipid measures among people with type 2 diabetes.
Limitations
- Six trials, 440 participants.
What this says about long-term health
Not established.